Status:
UNKNOWN
Develop Biomarkers for Assessing RA Joint Erosion
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Palo Alto Medical Foundation
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-65 years
Brief Summary
With the current therapeutic focus in rheumatoid arthritis (RA) shifting from symptom control to actual disease modification there is a growing demand for more objective and sensitive ways to evaluate...
Detailed Description
With the current therapeutic focus in rheumatoid arthritis (RA) shifting from symptom control to actual disease modification there is a growing demand for more objective and sensitive ways to evaluate...
Eligibility Criteria
Inclusion
- rheumatoid arthritis
Exclusion
- Nil
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
End Date :
May 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00154947
Start Date
May 1 2004
End Date
May 1 2006
Last Update
July 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liang-In Lin
Taipei, Taiwan